Search Results - "Pedrazzini, Giovanna"
-
1
Long‐term effects of primary graft dysfunction after heart transplantation
Published in Journal of cardiac surgery (01-05-2022)“…Background We studied the incidence of primary graft dysfunction (PGD), its impact on in‐hospital and follow‐up outcomes and searched for independent risk…”
Get full text
Journal Article -
2
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction
Published in Platelets (Edinburgh) (16-11-2020)“…Cangrelor is an intravenously administered P2Y receptor antagonist, which has been approved for adult patients undergoing percutaneous coronary intervention…”
Get full text
Journal Article -
3
Long-Term Follow-Up of Simultaneous Heart and Kidney Transplantation With Single Donor Allografts: Report of Nine Cases
Published in The Annals of thoracic surgery (01-08-2007)“…Background Combined heart-kidney transplantation is an accepted therapeutic option for patients with end-stage heart disease associated with severely impaired…”
Get full text
Journal Article -
4
-
5
-
6
Evaluation of Left Ventricular Overload and Use of Unloading Techniques in Venoarterial Extracorporeal Life Support: A Nationwide Survey
Published in ASAIO journal (1992) (01-04-2024)Get full text
Journal Article -
7
Home-based training to improve manual dexterity in patients with multiple sclerosis: A randomized controlled trial
Published in Multiple sclerosis (01-10-2015)“…Background: Impaired manual dexterity is frequent and disabling in patients with multiple sclerosis (MS), affecting activities of daily living (ADL) and…”
Get full text
Journal Article -
8
TCT-323 Predictors of clinical outcome and subsequent target lesion revascularization after percutaneous coronary procedures with drug eluting stents and everolimus eluting bioresorbable scaffolds for cardiac allograft vasculopathy
Published in Journal of the American College of Cardiology (01-11-2016)“…Percutaneous coronary intervention (PCI) has been considered palliative due to high restenosis rates, but still remains an alternative to the definitive…”
Get full text
Journal Article -
9
-
10
A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation
Published in Interactive cardiovascular and thoracic surgery (01-10-2016)“…OBJECTIVES In Europe, the age of heart donors is constantly increasing. Ageing of heart donors limits the probability of success of heart transplantation…”
Get full text
Journal Article -
11
Heart transplantation: 25 years’ single-centre experience
Published in Journal of cardiovascular medicine (Hagerstown, Md.) (01-09-2013)“…OBJECTIVESHeart transplantation (HTx) is still one of the most effective therapies for end-stage heart disease for patients with no other medical or surgical…”
Get full text
Journal Article -
12
Long-term results of lung cancer after heart transplantation: Single center 20-year experience
Published in Lung cancer (Amsterdam, Netherlands) (01-01-2009)“…Summary Objective The present study analyses, long-term lung cancer survival rate in the Niguarda heart transplant population and the results of surgical…”
Get full text
Journal Article -
13
Seltene Ursache eines spinozerebellären Syndroms
Published in Swiss medical forum (23-06-2015)Get full text
Journal Article -
14
Seltene Ursache eines spinozerebellären Syndroms
Published in Forum médical suisse (En ligne) (23-06-2015)Get full text
Journal Article -
15
Changes in patient survival and quality of life after heart transplantation
Published in Giornale italiano di cardiologia (2006) (01-07-2008)“…Heart transplantation was performed firstly in 1967, but it became a valuable option in the 1980s, due to the availability of cyclosporine and of the technique…”
Get more information
Journal Article -
16
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction
Published in Platelets (16-11-2020)“…Cangrelor is an intravenously administered P2Y 12 receptor antagonist, which has been approved for adult patients undergoing percutaneous coronary intervention…”
Get full text
Report